3D model is for representation purpose only.
.
.
RGDS | Estradiol-3-carboxymethyl ether |
Identification | |
---|---|
ConjuPepDB ID | cpd01144 |
Smiles | |
Molecular weight | 743.349 |
Molecular formula | C35H49N7O11 |
Chemical name | Peptide information |
Sequence (one letter) | RGDS |
Length | 4 |
Peptide name | tetrapeptide |
External ID | |
---|---|
CAS number | 906674-59-7 |
Other information | |
---|---|
Application | Osteoporosis therapy, estrogen replacement |
Additional function | improved potency and reduced side effects |
Pharmacological class | other |
Conjugate type | amide |
Linker | no |
Small molecule | Estradiol-3-carboxymethyl ether |
Small molecule CAS | 41164-36-7 |
Structure method | 1H NMR |
NMR solvent | DMSO-d9 |
Calculated properties | |
---|---|
LogP | -3.26867 |
Rotatable bonds | 18 |
H bond donor | 10 |
H bond acceptor | 14 |
Polar surface area (PSA) | 299.43000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates | 2007 | Xiong, Yu; Zhao, Ming; Wang, Chao; Chang, Heng Wei; Peng, Shiqi | Journal of Medicinal Chemistry |